Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

PeptiDream Inc. (PPTDF)

13.53
0.00
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
46,676,523
46,676,523
28,712,194
26,852,430
9,422,214
Cost of Revenue
12,172,699
12,172,699
11,493,476
8,738,942
2,393,436
Gross Profit
34,503,824
34,503,824
17,218,717
18,113,488
7,028,777
Operating Expense
13,389,982
13,389,982
10,445,669
9,133,292
2,962,530
Operating Income
21,113,842
21,113,842
6,773,048
8,980,196
4,066,247
Net Non Operating Interest Income Expense
-247,652
-247,652
-2,062,031
-2,123,596
309,901
Pretax Income
20,888,805
20,888,805
4,353,469
6,653,325
3,803,764
Tax Provision
5,873,882
5,873,882
1,317,636
-901,033
1,230,532
Net Income Common Stockholders
15,014,922
15,014,922
3,035,832
7,554,358
2,573,232
Diluted NI Available to Com Stockholders
15,014,922
15,014,922
3,035,832
7,554,358
2,573,232
Basic EPS
132.06
115.85
23.41
58.19
19.96
Diluted EPS
131.87
115.68
23.38
58.14
19.81
Basic Average Shares
129,609.62
129,610.17
129,699.94
129,829.58
128,904.15
Diluted Average Shares
129,779.95
129,793.07
129,841.29
129,935.50
129,925.96
Total Operating Income as Reported
21,113,841
21,113,841
6,773,047
8,980,196
4,066,246
Total Expenses
25,562,681
25,562,681
21,939,145
17,872,234
5,355,966
Net Income from Continuing & Discontinued Operation
15,014,922
15,014,922
3,035,832
7,554,358
2,573,232
Normalized Income
15,014,922
15,014,922
3,035,832
7,554,358
2,573,232
Interest Income
411,243
411,243
190,981
189,047
309,901
Interest Expense
658,895
658,895
2,253,012
2,312,643
--
Net Interest Income
-247,652
-247,652
-2,062,031
-2,123,596
309,901
EBIT
21,547,700
21,547,700
6,606,481
8,965,968
3,803,764
EBITDA
23,796,171
23,796,171
9,039,663
10,939,347
4,436,770
Reconciled Cost of Revenue
12,172,699
12,172,699
11,493,476
8,738,942
2,393,436
Reconciled Depreciation
2,248,471
2,248,471
2,433,182
1,973,379
633,006
Net Income from Continuing Operation Net Minority Interest
15,014,922
15,014,922
3,035,832
7,554,358
2,573,232
Total Unusual Items Excluding Goodwill
--
--
--
--
49,175
Total Unusual Items
--
--
--
--
49,175
Normalized EBITDA
23,796,171
23,796,171
9,039,663
10,939,347
4,436,770
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 8/20/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BPMUF Basilea Pharmaceutica AG
47.50
0.00%
 
GNMSF Genmab A/S
197.10
-1.45%
 
BVNKF Bavarian Nordic A/S
23.07
0.00%
 
INBX Inhibrx Biosciences, Inc.
12.26
+2.34%
 
HRMY Harmony Biosciences Holdings, Inc.
29.61
+0.61%
 
PTGX Protagonist Therapeutics, Inc.
44.49
-0.80%
 
GMAB Genmab A/S
20.59
+0.24%
 
RIGL Rigel Pharmaceuticals, Inc.
19.28
+1.15%
 
CHRS Coherus BioSciences, Inc.
1.0300
+1.98%
 
PCVX Vaxcyte, Inc.
32.92
-4.61%